Humoral hypercalcemia revealing a malignant non hodgkin lymphoma

被引:3
作者
Amezyane, T. [1 ]
Lecoules, S. [1 ]
Bordier, L. [1 ]
Blade, J. -S. [1 ]
Desrame, J. [1 ]
Bechade, D. [1 ]
Coutant, G. [1 ]
Algayres, J. -P. [1 ]
机构
[1] Hop Instruct Armees Val Grace, Clin Med, F-00446 Paris, France
关键词
hypercalcemia; non-Hodgkin lymphoma; PTH-rP; glucocorticoids; chemotherapy;
D O I
10.1016/j.ando.2007.10.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction. - Hypercalcemia is a rare complication of non-Hodgkin lymphoma. Usually, hypercalcernia occurs late in the disease course, except for high-grade lymphoma. Most often hypercalcernia is related to excessive level of circulating PTH-rP or sometimes, 1,25(OH)(2)D3. Concomitant high plasmatic concentration of PTH-rP and 1,25(OH)(2)D3 is uncommon. Exegesis. - We report the case of a 82-year-old man who presented with abdominal pain and weight loss, leading to the diagnosis of diffuse large-B-cell lymphoma (high-grade lymphoma) associated with symptomatic hypercalcemia (3.21 mmol/1). PTH-rP and 1,25(OH)(2)D3 plasmatic levels were high. Calcium concentration was normalized with glucocorticoids and sequential chemotherapy. Conclusion. - This case report confirms that hypercalcemia, as consequence of excessive plasmatic level of PTH-rP secreted by tumoral cells, can occur early in the course of high-grade lymphoma. Glucocorticoids and chemotherapy are the best treatment options. (c) 2007 Elsevier Masson SAS. Tons droits reserves.
引用
收藏
页码:58 / 62
页数:5
相关论文
共 23 条
  • [1] Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
    Black, Dennis M.
    Delmas, Pierre D.
    Eastell, Richard
    Reid, Ian R.
    Boonen, Steven
    Cauley, Jane A.
    Cosman, Felicia
    Lakatos, Peter
    Leung, Ping Chung
    Man, Zulema
    Mautalen, Carlos
    Mesenbrink, Peter
    Hu, Huilin
    Caminis, John
    Tong, Karen
    Rosario-Jansen, Theresa
    Krasnow, Joel
    Hue, Trisha F.
    Sellmeyer, Deborah
    Eriksen, Erik Fink
    Cummings, Steven R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) : 1809 - 1822
  • [2] Body Jean-Jacques, 2003, Rev Prat, V53, P2128
  • [3] Casez J -P., 2001, Eur J Intern Med, V12, P344, DOI 10.1016/S0953-6205(01)00124-8
  • [4] Alendronate and atrial fibrillation
    Cummings, Steven R.
    Schwartz, Ann V.
    Black, Dennis M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) : 1895 - 1896
  • [5] 1,25-DIHYDROXYVITAMIN D-RELATED HYPERCALCEMIA IN LYMPHOMA - 2 CASE-REPORTS
    DEVOGELAER, JP
    LAMBERT, M
    BOLAND, B
    GODFRAIND, C
    NOEL, H
    DEDEUXCHAISNES, CN
    [J]. CLINICAL RHEUMATOLOGY, 1990, 9 (03) : 404 - 410
  • [6] Farias Maria Lucia F de, 2005, Arq Bras Endocrinol Metabol, V49, P816
  • [7] Gaudin P, 1995, Rev Rhum Engl Ed, V62, P365
  • [8] Cancer and bone
    Guise, TA
    Mundy, GR
    [J]. ENDOCRINE REVIEWS, 1998, 19 (01) : 18 - 54
  • [9] Vitamin D-mediated hypercalcemia in lymphoma: Evidence for hormone production by tumor-adjacent macrophages
    Hewison, M
    Kantorovich, V
    Liker, HR
    Van Herle, AJ
    Cohan, P
    Zehnder, D
    Adams, JS
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (03) : 579 - 582
  • [10] A comparison of automated methods for the quantitation of serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D
    Kimball, Samantha M.
    Vieth, Reinhold
    [J]. CLINICAL BIOCHEMISTRY, 2007, 40 (16-17) : 1305 - 1310